Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

The Relation between Changes in Vitamin D and Vitamin B12 Levels, Body Mass Index and Outcome in Methadone Maintenance Treatment Patients

Bibliographic Data

ID13913360
AuthorsElad Malik (Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel), Lihi Rozner (Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, corresponding author), Miriam Adelson (0009-0005-1649-6260, Dr. Miriam and Sheldon G. Adelson Clinic for Drug Abuse Treatment and Research, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel), Shaul Schreiber (0000-0003-2254-7771, Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel), Einat Peles (Dr. Miriam and Sheldon G. Adelson Clinic for Drug Abuse Treatment and Research, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel)
Year2020
Volume53
Issue1
Pages55-64
Publication date2020-11-03
Open AccessNo
TypeARTICLE
VenueJournal of Psychoactive Drugs (JOURNAL)
Journal identifiersISSN: 0279-1072 • E-ISSN: 2159-9777
PublisherTaylor & Francis (PUBLISHER • GB)
DOI10.1080/02791072.2020.1840680
PMID33143561
OpenAlexW3095666525
LanguageEN
References cited58

Patients' Body Mass Index (BMI) increase during methadone maintenance treatment (MMT), and both Vitamins D and B12 deficiencies may be associated with BMI. We studied the relations between BMI, these vitamins and treatment outcome in patients with opioid use disorder receiving MMT. Vitamin B12 levels were available for 272 patients and Vitamin D levels were available for 260 patients. Of those 112 and 80 respectively had two measures (at admission or thereafter, and while stabilized or after one year in treatment). Patients' BMI levels and long-term retention were analyzed. Vitamin B12 was lower in patients abusing cocaine/amphetamine on admission. Vitamin D did not change over time, but a significant weight gain could be observed in 38 patients whose vitamin D was elevated compared to 42 whose levels were not, (25.4 ± 4.8 to 28.8 ± 5.2 vs. 24.3 ± 3.7 to 25.5 ± 4.0, p(Time) p = .04). Longer cumulative retention was observed among the elevated vitamin D group (8.1 years, 95% CI 6.3-9.8) in comparison with the non-elevated group (4.8y 95% CI 3.6-6.1, Kaplan Meier, p = .02). Stimulants misuse was associated with low B12 levels. Vitamin D elevation is associated with weight gain and longer retention in treatment

Anesthesia · Body mass index · Body weight · Methadone · Methadone maintenance · Opioid · Vitamin · Vitamin B12 · Vitamin D and neurology · Weight gain · Folate and B Vitamins Research · Medicine · Neurological and metabolic disorders · Pharmacological Effects and Toxicity Studies · Endocrinology · Gastroenterology · Internal Medicine

  • Depression Is a Risk Factor for Noncompliance With Medical Treatment

    M Robin Dimatteo, Heidi S Lepper et al.•A.M.A. Archives of Internal…•2000

  • Cognitive Function and Treatment Adherence in Older Adults With Heart Failure

    Michael L Alosco, Mary Beth Spitznagel et al.•Psychosomatic Medicine•2012

  • A vitamin profile of heroin addiction

    A el-Nakah, Oscar Frank et al.•American Journal of Public Health•1979

Highly citedNo

Tools

Open DOI
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae